Insilico Medicine falls 5% as AI drug discovery sector weakens

Insilico Medicine (3696.HK) fell 4.67% in Hong Kong trading to HK$34.32.

The AI drug discovery sector extended losses in Hong Kong, with AI-focused stocks broadly under pressure after the Hang Seng Tech Index dropped more than 5% the previous session.

Insilico recently entered an $888 million partnership with Servier, bringing its total signed deal value in 2026 to nearly $11 billion across six collaborations each exceeding $100 million.

Source: HK Stock Market Update The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.